Literature DB >> 12149180

Enhancing bowel adaptation in short bowel syndrome.

Palle Bekker Jeppesen1, Per Brobech Mortensen.   

Abstract

Malabsorption of both nonessential and essential nutrients, fluid, and electrolytes will, if not compensated for by increased intake, lead to diminished body stores and to subclinical and eventually clinical deficiencies. By definition, intestinal failure prevails when parenteral support is necessary to maintain nutritional equilibrium. After intestinal resection, adaptation, a progressive recovery from the malabsorptive disorder, may be seen. Research has focused on optimizing remnant intestinal function through dietary or pharmacologic interventions. In this review, factors responsible for the morphologic and functional changes in the adaptive processes are described. Results of clinical trials employing either growth hormone and glutamine or glucagon-like peptide-2 in short bowel patients are presented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149180     DOI: 10.1007/s11894-002-0085-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  115 in total

1.  Intestinal hypertrophy following partial resection of the small bowel in the rat.

Authors:  C C BOOTH; K T EVANS; T MENZIES; D F STREET
Journal:  Br J Surg       Date:  1959-01       Impact factor: 6.939

2.  Early proliferative activity in the left colon of the rat after partial small--bowel resection.

Authors:  M D Tilson; J T Michaud; E M Livstone
Journal:  Surg Forum       Date:  1976

3.  Dual-energy X-ray absorptiometry: fat estimation errors due to variation in soft tissue hydration.

Authors:  A Pietrobelli; Z Wang; C Formica; S B Heymsfield
Journal:  Am J Physiol       Date:  1998-05

4.  Effect of glutamine in short-bowel syndrome.

Authors:  J S Scolapio; K McGreevy; G S Tennyson; O L Burnett
Journal:  Clin Nutr       Date:  2001-08       Impact factor: 7.324

5.  Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

Authors:  J J Holst; T I Sørensen; A N Andersen; F Stadil; B Andersen; K B Lauritsen; H C Klein
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

6.  Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

Authors:  B Messing; P Crenn; P Beau; M C Boutron-Ruault; J C Rambaud; C Matuchansky
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

7.  Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection.

Authors:  D B Rountree; M H Ulshen; S Selub; C R Fuller; S R Bloom; M A Ghatei; P K Lund
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

8.  Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.

Authors:  J Szkudlarek; P B Jeppesen; P B Mortensen
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

9.  Biological determinants of intestinotrophic properties of GLP-2 in vivo.

Authors:  C H Tsai; M Hill; D J Drucker
Journal:  Am J Physiol       Date:  1997-03

10.  Absorption of short-chain fatty acids by the colon.

Authors:  H Ruppin; S Bar-Meir; K H Soergel; C M Wood; M G Schmitt
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

View more
  11 in total

Review 1.  The current status of small bowel transplantation in the UK and internationally.

Authors:  S J Middleton; N V Jamieson
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 2.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

3.  Glutamine-mediated dual regulation of heat shock transcription factor-1 activation and expression.

Authors:  Hongyu Xue; Dobromir Slavov; Paul E Wischmeyer
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

4.  Effect of ileo-jejunal transposition on ileal longitudinal smooth muscle contractility in vitro in rats.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Munenori Nagao; Hiroo Naito; Michiaki Unno; Ken-ichi Shiiba; Seiki Matsuno; Iwao Sasaki
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

5.  Short bowel syndrome.

Authors:  Neha R Parekh; Ezra Steiger
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

6.  Expression of growth hormone and its receptor in chronic atrophic gastritis and its clinical significance.

Authors:  Jian-Min Si; Qian Cao; Min Gao
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome.

Authors:  Thomas R Ziegler; Menghua Luo; Concepción F Estívariz; Daniel A Moore; Shanthi V Sitaraman; Li Hao; Niloofar Bazargan; Jan-Michael Klapproth; Junqiang Tian; John R Galloway; Lorraine M Leader; Dean P Jones; Andrew T Gewirtz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-14       Impact factor: 3.619

8.  Effects of bowel rehabilitation and combined trophic therapy on intestinal adaptation in short bowel patients.

Authors:  Guo-Hao Wu; Zhao-Han Wu; Zhao-Guang Wu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

9.  Nutrient intake from habitual oral diet in patients with severe short bowel syndrome living in the southeastern United States.

Authors:  Concepción F Estívariz; Menghua Luo; Kayellen Umeakunne; Niloofar Bazargan; John R Galloway; Lorraine M Leader; Thomas R Ziegler
Journal:  Nutrition       Date:  2008-04       Impact factor: 4.008

Review 10.  Intestinal transplantation.

Authors:  Olivier Goulet; Yann Révillon
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.